IFP Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $197K | Sell |
372
-264
| -42% | -$122K | ﹤0.01% | 1526 |
|
|
2026
Q1 | $305K | Sell |
636
-371
| -37% | -$190K | 0.01% | 1187 |
|
|
2025
Q4 | $566K | Buy |
1,007
+508
| +102% | +$288K | 0.01% | 877 |
|
|
2025
Q3 | $257K | Buy |
499
+305
| +157% | +$133K | 0.01% | 1175 |
|
|
2025
Q2 | $60.9K | Buy |
194
+134
| +223% | +$40.2K | ﹤0.01% | 1946 |
|
|
2025
Q1 | $18.3K | Buy |
60
+1
| +2% | +$336 | ﹤0.01% | 2323 |
|
|
2024
Q4 | $19.6K | Sell |
59
-93
| -61% | -$31.5K | ﹤0.01% | 2258 |
|
|
2024
Q3 | $50.7K | Sell |
152
-469
| -76% | -$178K | ﹤0.01% | 1728 |
|
|
2024
Q2 | $256K | Buy |
621
+456
| +276% | +$181K | 0.01% | 919 |
|
|
2024
Q1 | $66.7K | Sell |
165
-162
| -50% | -$57K | ﹤0.01% | 1469 |
|
|
2023
Q4 | $100K | Buy |
327
+156
| +91% | +$42.1K | ﹤0.01% | 1244 |
|
|
2023
Q3 | $41.4K | Buy |
171
+101
| +144% | +$25.8K | ﹤0.01% | 1636 |
|
|
2023
Q2 | $16.8K | Sell |
70
-52
| -43% | -$10.8K | ﹤0.01% | 2095 |
|
|
2023
Q1 | $5.2K | Sell |
122
-45
| -27% | -$9.31K | ﹤0.01% | 2549 |
|
|
2022
Q4 | $20K | Buy |
167
+83
| +99% | +$16.6K | ﹤0.01% | 2879 |
|
|
2022
Q3 | $4K | Buy |
84
+62
| +282% | +$9.89K | ﹤0.01% | 4139 |
|
|
2022
Q2 | $1K | Hold |
22
| – | – | ﹤0.01% | 4380 |
|
|
2022
Q1 | $1K | Buy |
22
+11
| +100% | +$1.81K | ﹤0.01% | 4379 |
|
|
2021
Q4 | $2K | Sell |
11
-17
| -61% | -$3.56K | ﹤0.01% | 2814 |
|
|
2021
Q3 | $5K | Hold |
28
| – | – | ﹤0.01% | 2560 |
|
|
2021
Q2 | $5K | Sell |
28
-11
| -28% | -$1.9K | ﹤0.01% | 2474 |
|
|
2021
Q1 | $6K | Sell |
39
-66
| -63% | -$10.1K | ﹤0.01% | 2351 |
|
|
2020
Q4 | $14K | Hold |
105
| – | – | ﹤0.01% | 1930 |
|
|
2020
Q3 | $12K | Sell |
105
-16
| -13% | -$1.85K | ﹤0.01% | 1841 |
|
|
2020
Q2 | $11K | Sell |
121
-14
| -10% | -$1.19K | ﹤0.01% | 1787 |
|
|
2020
Q1 | $11K | Buy |
135
+10
| +8% | +$868 | ﹤0.01% | 1732 |
|
|
2019
Q4 | $10K | Sell |
125
-7
| -5% | -$542 | ﹤0.01% | 1919 |
|
|
2019
Q3 | $10K | Buy |
+132
| New | +$9.97K | ﹤0.01% | 2079 |
|
|
2017
Q3 | – | Sell |
-43
| Closed | -$1K | – | 4149 |
|
|
2017
Q2 | $1K | Buy |
+43
| New | +$1.21K | ﹤0.01% | 3909 |
|
Other funds holding MEDP
WA
IFP Advisors's MEDP Position: Q2 2026 in Review
IFP Advisors reduced its Medpace (MEDP) stake by 42% in Q2 2026, selling an estimated $122K and leaving 372 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.
IFP Advisors first reported a position in MEDP in Q2 2017 and has held it in 29 quarters since. The position peaked at $566K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- IFP Advisors held 372 shares of Medpace worth $197K as of Q2 2026.
- IFP Advisors sold 264 Medpace shares in Q2 2026, an estimated $122K.
- Medpace made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1526 holding.
- IFP Advisors first reported a position in Medpace in Q2 2017 and has held it in 29 quarters since.
- IFP Advisors's Medpace position peaked at $566K in Q4 2025.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.